Clinical Trial Update: Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of TEL/AML/CTD in elderly patients with essential hypertension, sponsored by Yuhan Corporation, is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• TEL/AML/CTD

Snippet

Sponsor: Yuhan Corporation | Conditions: Essential Hypertension | Status: ACTIVE_NOT_RECRUITING